StemRIM

Tokyo Stock Exchange 4599.T

StemRIM Dividends Paid for the year ending July 31, 2024: USD 0.00

StemRIM Dividends Paid is USD 0.00 for the year ending July 31, 2024, a 0.00% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

StemRIM Dividends Paid for the year ending July 31, 2023 was USD 0.00, a 0.00% change year over year.
StemRIM Dividends Paid for the year ending July 31, 2022 was USD 0.00, a 0.00% change year over year.
StemRIM Dividends Paid for the year ending July 31, 2021 was USD 0.00, a 0.00% change year over year.
StemRIM Dividends Paid for the year ending July 31, 2020 was USD 0.00, a 0.00% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Tokyo Stock Exchange: 4599.T

StemRIM

CEO	Mr. Masatsune Okajima
IPO Date	Aug. 9, 2019
Location	Japan
Headquarters	Saito Bio-Incubator
Employees	45
Sector	Healthcare
Industries Biotechnology

Description

StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.

Key trends

Past 5 years